Priovant Therapeutics
Durham, United States (US) · Health and Medical
Do your work at Priovant Therapeutics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
Priovant Therapeutics is a clinical-stage biotechnology company developing targeted therapies for patients with severe autoimmune disease.
We are rapidly developing a pipeline of medicines, including oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications.
Our approach focuses on unlocking new treatment options for patients who are underserved by existing therapies, addressing significant morbidity and mortality associated with these conditions. We are committed to advancing innovative medicines to improve the lives of patients living with autoimmune diseases.
Priovant Therapeutics is headquartered in Durham, North Carolina, and employs 131 people.
We are rapidly developing a pipeline of medicines, including oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications.
Our approach focuses on unlocking new treatment options for patients who are underserved by existing therapies, addressing significant morbidity and mortality associated with these conditions. We are committed to advancing innovative medicines to improve the lives of patients living with autoimmune diseases.
Priovant Therapeutics is headquartered in Durham, North Carolina, and employs 131 people.
Contact Details
info@priovant.com
Durham, United States (US)
Company Type
Private Limited Company
Employees
100-150
Categories
Keywords
You're invisible in searches for:
Add keywords that describe your company, services, or market to improve your visibility in search results.
Companies teams usually look at after Priovant Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.